Basel Medical Group Ltd Files 6-K with Financials
Ticker: BMGL · Form: 6-K · Filed: Jun 18, 2025 · CIK: 2004489
| Field | Detail |
|---|---|
| Company | Basel Medical Group LTD (BMGL) |
| Form Type | 6-K |
| Filed Date | Jun 18, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-statements, 6-K, foreign-private-issuer
TL;DR
Basel Medical Group Ltd dropped its latest financials (6-K) for Dec 2023/2024 - check the 20-F for annuals.
AI Summary
Basel Medical Group Ltd filed a Form 6-K on June 18, 2025, reporting unaudited consolidated financial statements and management's discussion for the six months ended December 31, 2023, and 2024. The company is a foreign private issuer and will file annual reports under Form 20-F.
Why It Matters
This filing provides investors with updated financial performance data for Basel Medical Group Ltd, crucial for assessing the company's recent operational and financial health.
Risk Assessment
Risk Level: low — This is a routine filing of financial statements and management discussion, not indicating any immediate material adverse events.
Key Players & Entities
- Basel Medical Group Ltd (company) — Filer of the 6-K report
- June 18, 2025 (date) — Filing date of the report
- December 31, 2023 (date) — End of reporting period for financial statements
- December 31, 2024 (date) — End of reporting period for financial statements
- Form 20-F (document) — Annual report form the company will file
- Form 6-K (document) — Type of report filed
FAQ
What specific financial periods are covered by the unaudited consolidated financial statements?
The unaudited consolidated financial statements cover the six months ended December 31, 2023, and December 31, 2024.
What is the filing date of this Form 6-K report?
This Form 6-K report was filed on June 18, 2025.
What type of annual reports does Basel Medical Group Ltd file?
Basel Medical Group Ltd files its annual reports under cover of Form 20-F.
What are the included exhibits in this filing?
The included exhibits are 99.1 (Unaudited Consolidated Financial Statements for the Six Months Ended December 31, 2023 and 2024) and 99.2 (Management’s Discussion and Analysis of Financial Conditions and Results of Operations for the Six Months Ended December 31, 2023 and 2024).
What is the principal executive office address of Basel Medical Group Ltd?
The principal executive office address is 6 Napier Road, Unit #02-10/11 Gleneagles Medical Centre, Singapore 258499.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 18, 2025 regarding Basel Medical Group Ltd (BMGL).